ENVB Earnings Enveric Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.08 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -36.24 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -35.74 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.15 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -14.58 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -228.48 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | -170.67 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -11.22 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -9.21 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -121.29 | 2025-03-28 | 10-K |
| Q3 2024 | 2023-09-30 | -6.62 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -5.35 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -2.31 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -13.00 | 2024-03-26 | 10-K |
| Q3 2023 | 2022-09-30 | -8.11 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -7.78 | 2023-08-11 | 10-Q |
| Q3 2020 | 2020-09-30 | -1.11 | 2020-11-16 | 10-Q |
| Q2 2020 | 2020-06-30 | -1.03 | 2020-08-14 | 10-Q |
| Q1 2020 | 2020-03-31 | -0.60 | 2020-05-15 | 10-Q |
| FY 2019 | 2019-12-31 | -2.83 | 2020-03-25 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.